Malondialdehyde-modified LDL as a marker of acute coronary syndromes

JAMA

Volumn 281, Issue 18, 1999, Pages 1718-1721

  Holvoet, Paul ^a   Collen, Désiré ^a   Van De Werf, Frans ^b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE; TROPONIN I;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; LIPID ANALYSIS; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; UNSTABLE ANGINA PECTORIS;

EID: 0033549128     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.281.18.1718     Document Type: Article

References (16)

1. 2-isoprostanes) in plasma of low density-lipoprotein exposed to oxidative stress in vitro. J Clin Invest. 1994; 93:998-1004.
2. Haberland ME, Fong D, Cheng L. Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits. Science. 1988;241:215-218.
3. Holvoet P, Perez G, Zhao Z, Brouwers E, Bernar H, Collen D. Malondialdehyde-modified low density lipoproteins in patients with atherosclerotic disease. J Clin Invest. 1995;95:2611-2619.
4. Holvoet P, Vanhaecke J, Janssens S, Van de Werf F, Collen D. Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease. Circulation. 1998;98:1487-1494.
5. Oltrona L, Merlini PA, Pezzano A. C-reactive protein and serum amyloid A protein in unstable angina. N Engl J Med. 1995;332:399-400.
6. Adams JE III, Bodor GS, Davila-Roman VG, et al. Cardiac troponin. Circulation. 1993;88:101-106.
7. Antman EM, Tanasijevic MJ, Thompson B, et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med. 1996;335:1342-1349.
8. Ohman EM, Armstrong PW, Christenson RH, et al. Cardiac troponin T levels for risk stratification in acute myocardial ischaemia. N Engl J Med. 1996;335:1333-1341.
9. Van de Werf F. Cardiac troponins in acute coronary syndromes. N Engl J Med. 1996;335:1388-1389.
10. Holvoet P, Stassen JM, Van Cleemput J, Collen D, Vanhaecke J. Oxidised low density lipoproteins in patients with transplant-associated coronary artery disease. ArteriosclerThromb VascBiol. 1998;18:100-107.
11. Zweig MH, Broste SK, Reinhart RA. ROC curve analysis. Clin Chem. 1992;38:1425-1428.
12. Mach F, Lovis C, Gaspoz JM, et al. C-reactive protein as a marker for acute coronary syndromes, Eur Heart J. 1997;18:1897-1902.
13. Hamm CW, Goldmann BU, Heeschen C, et al. Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I. N Engl J Med. 1997;337:1648-1653.
14. Galvani M, Ottani F, Ferrini D, et al. Prognostic influence of elevated values of cardiac troponin I in patients with unstable angina. Circulation. 1997;95: 2053-2059.
15. Farber HW, Barnett HF. Differences in prostaglandin metabolism in cultured aortic and pulmonary arterial endothelial cells exposed to acute and chronic hypoxia. Circ Res. 1991;68:1446-1457.
16. 2-isoprostanes) are formed in situ on phospholipids. Proc Natl Acad Sci U S A. 1992;89:10721-10725.